SOPHiA GENETICS (SOPH) Work In Process (2020 - 2021)

SOPHiA GENETICS (SOPH) reported Work In Process of $1.3 million for Q4 2021, up 84.21% on a YoY basis from $722000.0 in Q4 2020, and up 84.21% sequentially from $722000.0 in Q4 2020.

SOPHiA GENETICS (SOPH) Work In Process (2020 - 2021) Analysis & Trends

SOPHiA GENETICS (SOPH) has 2 years of Work In Process data on file, last reported at $1.3 million in Q4 2021.

  • For the quarter ending Q4 2021, Work In Process rose 84.21% year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2021 stood at $1.3 million (up 84.21% YoY), and the FY2021 full-year result was $1.3 million, up 84.21% from the prior year.
  • Work In Process rose to $1.3 million in Q4 2021, from $722000.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $1.3 million in Q4 2021 to a low of $722000.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 31.70 Bn 24.39 Bn 662.02 Mn
2 BrightSpring Health Services 14.70 Bn 13.80 Bn 482.22 Mn
3 Healthequity 8.30 Bn 8.04 Bn 256.31 Mn
4 Hinge Health 5.94 Bn 5.62 Bn 154.23 Mn
5 10x Genomics 5.86 Bn 5.32 Bn 106.18 Mn
6 MiniMed 4.47 Bn 4.17 Bn 480.00 Mn
7 Waystar Holding 4.45 Bn 4.39 Bn 216.84 Mn
8 Doximity 3.94 Bn 3.19 Bn 125.97 Mn
9 Privia Health 3.18 Bn 2.76 Bn -
10 SOPHiA GENETICS 390.04 Mn 319.75 Mn 14.69 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 1.33 Mn
Dec 31, 2020 722,000.00